Bioniz Therapeutics Announces Positive Phase 1b Clinical Study Results for Investigational Agent BNZ-1 Read more
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab Read more
Over 20 presentations on developments in the field of analgesic medicine at the SMi event in London Read more
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home Read more
AbbVie Submits BLA to FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis Read more
Concert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata Read more